| Jessica Coulson, | |
|
3901 Teays Valley Rd, Hurricane, WV 25526-9604 | |
| (304) 760-1123 | |
| (304) 760-1131 |
| Full Name | Jessica Coulson |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3901 Teays Valley Rd, Hurricane, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528634698 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP0008013 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Coulson, Po Box 57, Buffalo, WV 25033-0057 Ph: () - | Jessica Coulson, 3901 Teays Valley Rd, Hurricane, WV 25526-9604 Ph: (304) 760-1123 |
News Archive
New research has uncovered a process that is defective in patients with autosomal dominant polycystic kidney disease, a common cause of kidney failure. The findings, which appear in an upcoming issue of the Journal of the American Society of Nephrology (JASN), point to a new potential strategy for preventing and treating the disease.
Jonathan Grein, MD, Cedars-Sinai medical director of Hospital Epidemiology, is available to discuss ways to keep healthy as flu activity surges dramatically.
Researchers of H5N1 bird flu virus "are set to wrap up a two-day meeting on the issue Friday with international experts at the World Health Organization in Geneva" with the aim of settling controversy over the work of two research teams that created genetically altered viral strains that are easily transmissible among ferrets, a laboratory model for humans, the Associated Press reports (Mason, 2/17).
Researchers have successfully tried a biodegradable bridge like device (biodegradable polycaprolactone PCL conduit) in vivo for management of nerve injuries. The team published their findings in a paper titled, "Long-gap peripheral nerve repair through sustained release of a neurotrophic factor in nonhuman primates," in the latest issue of the journal Science Translational Medicine.
Maxim Pharmaceuticals today announced that its treatment protocol to provide its investigational drug Ceplene(TM), in combination with interleukin-2 (IL-2), for the treatment of patients with advanced malignant melanoma, has been approved by the U.S. Food and Drug Administration (FDA).
› Verified 8 days ago
Katherine Ellen King, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3000 Teays Valley Rd, Hurricane, WV 25526 Phone: 304-562-1830 | |
James Aaron Pauley, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 167 Progress Way, Hurricane, WV 25526 Phone: 304-562-3556 | |
Dr. Joseph Martin Hensley, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 68 Shannon Dr, Hurricane, WV 25526 Phone: 304-610-7305 | |
Sara E. Babcock, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3109 Teays Valley Rd, Hurricane, WV 25526 Phone: 304-562-2677 Fax: 304-562-0629 | |
Eric Lambert, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4016 State Route 34, Hurricane, WV 25526 Phone: 304-757-7318 | |
Mr. Steven Everett Cunningham, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4016 State Route 34, Hurricane, WV 25526 Phone: 304-757-7318 Fax: 304-757-4731 | |
Taegan Morgan, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4016 State Route 34, Hurricane, WV 25526 Phone: 304-757-7318 |